Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01436435 · ClinicalTrials.gov registry record · Phase 4
The Jetstream (JET) Post-market Registry
A Phase 4 study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 4
- Development phase
- 241
- Enrollment target
NCT01436435: Completed Phase 4 study, sponsored by Boston Scientific Corporation.
NCT01436435 is a Phase 4 study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 241 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01436435, a Phase 4 study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 241 participants
- Enrollment target
Study Summary
The scope of the JET registry to observe long term treatment effects of Jetstream Navitus on various lesions types/morphologies.
Primary Outcome
Percentage of patients with binary restenosis at 12 months as defined by duplex ultrasound derived systolic velocity ratio \>2.5. Binary restenosis will be measured by duplex ultrasound technology.
Interventions
- DEVICE Jetstream Atherectomy System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2011-09 |
| Est. Completion | 2016-02 |
| Phase | Phase 4 |
What the finished NCT01436435 record still lists
NCT01436435 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (53% lower).
The record links to 0 conditions, and to 1 intervention - of which Jetstream Atherectomy System is the first listed.
NCT01436435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01436435 about?
NCT01436435 is a clinical study titled "The Jetstream (JET) Post-market Registry". The scope of the JET registry to observe long term treatment effects of Jetstream Navitus on various lesions types/morphologies.
What is the current status of trial NCT01436435?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 241 participants. The study started on 2011-09. Estimated completion is 2016-02.
What interventions are being tested in trial NCT01436435?
The interventions under investigation include: Jetstream Atherectomy System (DEVICE).
Who is sponsoring clinical trial NCT01436435?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01436435's enrollment target sits among peer trials
241 360th of 2000 higher than 1,641 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia